Vivani Medical, Inc. (VANI) Stock Forecast

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

4d ago, source: Yahoo Finance

Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing ...

Vivani Medical Reports Q2 2025 Results and $10M Financing

4d ago, source: None

Vivani Medical, Inc. ( ($VANI) ) has released its Q2 earnings. Here is a breakdown of the information Vivani Medical, Inc. presented to its ...

EXCLUSIVE: Vivani Prioritizes Semaglutide-Based Implant After Promising Preclinical Data

13d ago, source: Benzinga

Vivani reported Phase 1 success for its exenatide implant and shared preclinical semaglutide data showing 231-day weight loss ...

Vivani Medical Secures $10M Through Share Purchase Agreement

4d ago, source: None

Vivani Medical ( ($VANI) ) has shared an update. On August 11, 2025, Vivani Medical entered into a Share Purchase Agreement to sell 7,936,507 ...

Vivani Medical, Inc.: Vivani Medical Provides Business Update Including ...

3mon ago, source: Finanznachrichten

ALAMEDA, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a biopharmaceutical company developing miniaturized, ultra long-acting drug ...

Vivani Medical Announces Public Filing of Registration Statement for ...

2y ago, source: Business Wire

Vivani represents the August 2022 merger of Second Sight and Nano Precision Medical, Inc. NPM-119 is being developed within Vivani’s Biopharm Division (formerly Nano Precision Medical, Inc.).

Vivani Medical: Q2 Earnings Snapshot

4d ago, source: Chron

ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Vivani Medical, Inc. (VANI) on Wednesday reported a loss of $7.1 million in its second quarter. The Alameda, California-based company said it had a loss ...

Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early ...

2y ago, source: Nasdaq

Vivani Medical, Inc., an innovative, near-clinical stage biopharmaceutical company that is developing novel, miniature, long-term therapeutic implants, announced today that its wholly-owned ...

Vivani Medical Announces $1 Million NIH Grant Funding to Support ...

2y ago, source: Morningstar

Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an emerging biopharmaceutical company which develops miniaturized, subdermal implants today announced that the Company ...

Vivani Medical to Present at the ThinkEquity Investor Conference

2y ago, source: Business Wire

Vivani represents the August 2022 merger of Second Sight Medical Products, Inc., and Nano Precision Medical, Inc. NPM-119 is being developed within Vivani’s Biopharm Division (formerly Nano ...

Vivani Medical to Present at the 2025 BIO International Convention

2mon ago, source: Seeking Alpha

Dr. Mendelsohn will highlight Vivani’s innovative, miniature drug implants, powered by its proprietary NanoPortal™ drug implant technology. These ultra long-acting implants are designed to ...

Vivani Medical, Inc.: Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

4d ago, source: FinanzNachrichten.de

Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing preclinical study of NPM-139 and promising results from the LIBERATE-1 Phase 1 clini ...

Company	Ticker	90 Days Forecast	Market Cap. (USD M)	P/E	P/B
Axogen, Inc.	AXGN	Predict	683.28	-41.70	6.09
BIOLIFE SOLUTIONS INC	BLFS	Predict	990.70	-14.65	2.81
BioSig Technologies, Inc.	BSGM	Predict	126.37	-1.82	48.51
Ceribell, Inc.	CBLL	Predict	450.54	None	2.62
CONMED Corp	CNMD	Predict	1656.44	15.03	1.65
CUTERA INC	CUTR	Predict	9.08	-0.06	-0.04
CapsoVision, Inc	CV	Predict	-0.32	None	None
electroCore, Inc.	ECOR	Predict	39.09	-7.26	35.12
EDAP TMS SA	EDAP	Predict	50.85	None	1.24
Electromed, Inc.	ELMD	Predict	170.00	23.74	3.87
FONAR CORP	FONR	Predict	95.72	9.22	0.61
GUIDED THERAPEUTICS INC	GTHP	Predict	21.72	None	None
HELIUS MEDICAL TECHNOLOGIES, INC.	HSDT	Predict	66.46	-0.04	51.92
Hyperfine, Inc.	HYPR	Predict	147.70	-1.83	0.89
InMode Ltd.	INMD	Predict	1156.56	None	1.64
IRIDEX CORP	IRIX	Predict	19.00	-2.75	3.14
IR-Med, Inc.	IRME	Predict	1.37	None	None
Integer Holdings Corp	ITGR	Predict	3826.29	46.29	2.25
LivaNova PLC	LIVN	Predict	2932.59	-662.01	2.61
MASIMO CORP	MASI	Predict	8447.46	128.12	8.10
Medtronic plc	MDT	Predict	120566.14	25.86	2.51
Movano Inc.	MOVE	Predict	5.42	-8.57	0.74
ENDRA Life Sciences Inc.	NDRA	Predict	1.92	-0.78	1.10
Neuraxis, INC	NRXS	Predict	23.76	-0.86	5.59
Nuwellis, Inc.	NUWE	Predict	64.73	-0.06	18.09
Nexalin Technology, Inc.	NXL	Predict	13.66	-4.68	2.29
Nexalin Technology, Inc.	NXLIW	Predict	4.77	None	0.96
Outset Medical, Inc.	OM	Predict	236.11	-0.41	1.52
PRECISION OPTICS CORPORATION, INC.	POCI	Predict	36.49	-11.54	2.77
QT IMAGING HOLDINGS, INC.	QTI	Predict	7.20	-0.42	-0.75
SOLENO THERAPEUTICS INC	SLNO	Predict	4416.52	-18.46	19.02
Semler Scientific, Inc.	SMLR	Predict	463.22	12.50	1.21
STAR EQUITY HOLDINGS, INC.	STRR	Predict	6.87	-1.60	0.11
STAR EQUITY HOLDINGS, INC.	STRRP	Predict	30.45	-5.50	0.49
Stereotaxis, Inc.	STXS	Predict	1112.32	-8.43	763.96
Tivic Health Systems, Inc.	TIVC	Predict	3.66	-0.03	0.99
TransMedics Group, Inc.	TMDX	Predict	5138.86	71.71	16.16
Vivani Medical, Inc.	VANI	Predict	91.83	-2.67	7.90
VASO Corp	VASO	Predict	22.85	20.10	0.86
ZYNEX INC	ZYXI	Predict	47.01	41.41	37.28